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Dicer is an RNase III-family nuclease that initiates RNA interference
(RNAi) and related phenomena by generation of the small RNAs
that determine the specificity of these gene silencing pathways.
We have previously shown that Dicer is essential for mammalian
development, with Dicer-deficient mice dying at embryonic day 7.5
with a lack of detectable multipotent stem cells. To permit a more
detailed investigation of the biological roles of Dicer, we have
generated embryonic stem cell lines in which their single Dicer
gene can be conditionally inactivated. As expected, Dicer loss
compromises maturation of microRNAs and leads to a defect in
gene silencing triggered by long dsRNAs. However, the absence of
Dicer does not affect the ability of small interfering RNAs to repress
gene expression. Of interest, Dicer loss does compromise the
proliferation of ES cells, possibly rationalizing the phenotype
previously observed in Dicer-null animals. Dicer loss also affects the
abundance of transcripts from mammalian centromeres but does
so without a pronounced affect on histone modification status at
pericentric repeats or methylation of centromeric DNA. These
studies provide a conditional model of RNAi deficiency in mammals
that will permit the dissection of the biological roles of the RNAi
machinery in cultured mammalian cells.
centromeres  RNA interference
D icer is a multidomain ribonuclease with specificity for dsRNA.Dicer’s catalytic role in the production of small RNAs is
central to dsRNA-mediated gene silencing or RNA interference
(RNAi) (1–3).Dicer is essential for the response ofmany organisms
to dsRNAs encountered from exogenous sources, including those
generated by viral infection or those that have been experimentally
delivered. Additionally, Dicer must process endogenous dsRNAs
that trigger silencing responses directed at repetitive elements such
as transposons and centromeric sequences. Finally, Dicer must
promote the maturation of endogenous noncoding RNAs, the
microRNAs (miRNAs) that enter the RNAi pathway to regulate
the expression of protein coding genes. In all of these cases, Dicer
is directly responsible for producing from a longer precursor the
22-nt dsRNAs bearing signature 2-nt 3 overhangs that are a
hallmark of RNAi and related pathways.
The Dicer enzyme is organized as a modular structure, with
a canonical Dicer containing an N-terminal DEAD-box helicase
domain, a domain of unknown function (DUF283), a PAZ
domain, a pair of catalytic RNaseIII domains, and a C-terminal
dsRNA-binding domain. Structural models of Dicer predict that
the RNaseIII domains combine as an intramolecular dimer to
produce a single compound catalytic center that measures the
position of scissile bonds precisely from an end of its dsRNA
substrate (4–7).
Mounting evidence also suggests additional roles for Dicer
enzymes. InDrosophila, Dcr-2 acts, along with its partner R2D2, in
a loading complex responsible for sensing small interfering RNA
(siRNA) asymmetry and placing the correct strand of the siRNA
into RISC (8–13). Similar activities must also exist for miRNAs
because one strand of the precursor miRNA predominantly con-
tributes to the production of a functionalRISC (12, 13). Inmice and
humans, Dicer is encoded by a single locus, whose protein product
must account for all proposed Dicer activities.
Based on genetic studies in other systems, mouse Dicer has a
predicted involvement in numerous biological processes. Thus, it is
not surprising that Dicer-deficient mice die very early in develop-
ment, around embryonic day 7.5, with essentially a complete loss of
pluripotent stem cells (1). In addition, mouse embryos hypomor-
phic for Dicer die mid-gestation (14). Dicer-deficient zebrafish
progress much further in development, probably owing to the
presence of maternally deposited Dicer transcripts (15). Depletion
of maternal Dicer achieved by germ-line transplantation in ze-
brafish revealed that Dicer is required for morphogenesis but not
cell fate specification during zebrafish embryogenesis and that the
absence of miRNAs is responsible, at least in part, for this pheno-
type (16).
Recently it has become clear that Dicer is essential for viability
and proliferation of some cell types but is dispensable for others.
Chicken DT40 cells in which Dicer has been inactivated by homol-
ogous recombination become aneuploid and undergo growth arrest
upon loss of Dicer (17). Specific deletion of Dicer during T cell
development in the mouse thymus showed that survival is com-
promised in the  but not  lineage, but that transcriptional gene
silencing during CD48 differentiation is not perturbed (18). In
addition,Dicer-deficientmouseES cells selected for survival in vitro
are defective in differentiation (19). These phenotypes are consis-
tent with an essential role for Dicer, at least in some cell types, in
cellular metabolism and proliferation. However, the precise under-
lying cause of the requirement for Dicer in these cells remains
unclear.
A series of recent studies has implicated the RNAi machinery in
the establishment and maintenance of heterochromatin at centro-
meres (17, 19–27). In Schizosaccharomyces pombe, mutants in the
RNAi pathway have a number of mitotic and meiotic defects and
display a loss of heterochromatin at the centromeres and a dere-
pression of transcription of centromeric repeats (20, 21, 26–28).
Roles for RNAi at heterochromatic mating-type loci are more
restricted, with the machinery mainly acting during the initiation
phase rather than in the maintenance of heterochromatin (21, 25,
29). Similar roles for RNAi in the husbandry of repetitive elements
and formation of heterochromatin have been observed in Tetrahy-
mena (22, 30), chicken DT40 cells (17), mouse ES cells (19), and
plants (31) but notably not in Neurospora (32–34). We set out to
examinemodels ofDicer function inmammalian cells by expanding
on our earlier constitutive mutant animals through the creation of
conditional Dicer-null ES cells.
ES cells are a transient pluripotent cell population found in the
mammalian blastocyst that can be isolated and cultured in vitro
without a loss of their ability to contribute to all mouse tissues.
Mouse ES cells contain Dicer and express a substantial number of
miRNAs, including some that are unique to ES cells (35). Here we
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describe the creation and characterization of Dicer conditional ES
cell lines that can be induced to inactivate Dicer upon exposure to
Cre recombinase. We find that, upon loss of Dicer activity, ES cells
have a significant proliferation defect. However, this defect can be
overcome with time, probably because of the accumulation of
additional mutations. As expected, Dicer-deficient ES cells are
unable to process pre-miRNAs or dsRNAs. Interestingly, Dicer-
null cells are still able to mount an siRNA-mediated gene silencing
response. In addition, ES cells lacking Dicer accumulate transcripts
derived from the centromeric major satellite but retain the integrity
of centromeric heterochromatin as indicated by the presence of
cytosine methylation and histone H3 lysine 9 trimethylation.
Materials and Methods
Gene Targeting and Cell Culture. 4E4Dicer heterozygousES cells (1)
were electroporated with the linearized conditional targeting con-
struct and selected with puromycin. ES cells were grown on a STO
feeder layer or on gelatin-coated plates with media supplemented
with leukemia inhibitory factor.
Transfection and FACS. ES cells were transfected with pCMV-Cre-
EGFP (a gift from D. Lee and D. W. Threadgill, University of
North Carolina, Chapel Hill) by using Lipofectamine 2000 at 5
gml and pCMV-Cre-EGFP at 1.5 gml. GFP-positive cells
were enriched by sorting with a FACSVantage DiVa cell sorter
(BectonDickinson). Cell-cycle analysis was done by using an LSRII
FACS analyzer (Becton Dickinson). Cells were fixed and stained
with propidium iodide before analysis, and 25,000 cells were
analyzed per genotype.
Southern and Northern Analyses. Southern blot was probed over-
night with either the genotyping probe (flox forward, TTG-
GAGCTGTCTAGTTAGTTATGC; flox reverse, GTTGCAA-
GATAAACATGGTCACAA) or the minor satellite probe
(JPO106, AGTGTATATCAATGAGTTACAATG; JPO107,
CATCTAATATGTTCTACAGTGTGG). The major satellite
probe and mitochondrial probes were a gift from T. Bestor (Co-
lumbia University, New York) (36). Probes used for miRNA
Northern blots were as follows: miR292-as, ACACTCAAAAC-
CTGGCGGCACTT; miR293, ACACTACAAACTCTGCG-
GCACT; miR19b, TCAGTTTTGCATGGATTTGCACA (35);
U6 snRNA, GCTTCACGAATTTGCGTGTCATCCT.
Antibodies and Western Blots. Whole-cell extract was probed with
DICER8 (obtained from the W. Filipowicz laboratory, Friedrich
Miescher Institute, Basel) (37) and Dicer 1416 (obtained from the
D. Livingston laboratory, Dana Farber Cancer Institute, Boston).
dsRNA and siRNA Silencing Assays. dsRNA was prepared by using a
Megascript kit (Ambion) according to the manufacturer’s direc-
tions. T7-tagged firefly luciferase dsRNAwas amplified frompGL3
template (Promega) with the following primer sequences: TAAT-
ACGACTCACTATAGGGATAAAGAAAGGCCCGGCGCC
(firefly luciferase forward) and TAATACGACTCACTATAGG-
GACGAACGTGTACATCGACTGAAAT (firefly luciferase re-
verse). pEGFP-N1 (Clontech) was used as a PCR template forGFP
dsRNA, using primers TAATACGACTCACTATAGGGATC-
CTGGTCGAGCTGGAC (T7 GFP forward) and TAATAC-
GACTCACTATAGGGTGCTCAGGTAGTGGTTGT (T7 GFP
reverse). DsRNA was transfected into ES cells by using Lipo-
fectamine 2000 (Invitrogen) at 10 gml with dsRNA at a con-
centration of 2 gml, along with reporter plasmids pSV40renilla
and pGL3 (Promega) at 0.1 gml and 1 gml concentrations,
respectively. siRNAs were transfected into ES cells at a total
concentration of 100 nM, with the total concentration being
maintained by mixing variable ratios of target siRNA and control
siRNA. Luciferase activity was measured 48 h after transfection by
using a Dual Luciferase Detection Kit (Promega).
cDNA Preparation and Quantitation. A total of 0.1 g of purified
RNA was used in cDNA synthesis with 0.1 g of random nonamer
primers in a 20-l reaction volume. One microliter of this cDNA
was used as template for quantitative PCR analysis of actin tran-
script levels with actin forward and actin reverse primers (actin
forward, ACCCACACTGTGCCCATCTAC; actin reverse, AGC-
CAAGTCCAGACGCAGG). Relative amplification of duplicate
samples for each cDNA was compared with 5-fold serial dilutions
of wild-type AB2.2 cDNA, with Ct values plotted against log
dilutions. For centromeric transcript analyses, 1 g of RNA was
used for cDNA synthesis with oligo T12, random nonamers, MajF1,
or MajR1 (MajF1, GACGACTTGAAAAATGACGAAATC;
MajR1, CATATTCCAGGTCCTTCAGTGTGC) (38). One mi-
croliter of this cDNA was used for PCR analysis of satellite
transcripts. Products were stained with ethidium bromide before
photography. PCRs performed with 25 cycles were ‘‘spiked’’ by
addition of [-32P]dCTP, and products were fractionated on 4%
polyacrylamide gels before drying gels and quantifying bands by
phosphoimaging.
Chromatin Immunoprecipitations. Chromatin immunoprecipitations
were done by using anti-trimethyl H3K9 antibody (1:100, Upstate
Biotechnology, Lake Placid, NY) according to Upstate Biotech-
nology protocol. ImmunoprecipitatedDNAwas used in PCRs with
primers specific for the major satellite (38).
Results
Generation of Dicer-Deficient ES Cells. To generate ES cells that
conditionally express Dicer, we replaced a wild-type Dicer allele
with a floxed allele in ES cells that already contained a null Dicer
allele (1) (Fig. 1).We screened puromycin-resistant clones for those
in which the intact allele of Dicer had been replaced by the floxed
allele. In these clones, we expected that functional Dicer would be
expressed from the floxed locus, in which exons 22 and 23, encoding
the majority of both catalytic RNaseIII domains, were flanked by
loxP sites (Fig. 1).
To examine the phenotypic effects of Dicer loss, we used the
Dicerflox/null clones to generate Dicer-deficient cells. Expression of
Cre recombinase in Dicerflox/null ES cells was expected to lead to
recombination between the loxP sites and excision of exons 22 and
23, resulting in Dicer-deficient ES cells. We transiently expressed
Cre by transfection of a Cre-expression plasmid, plated cells onto
gelatin-coated plates, and analyzed the plates by Southern blotting
for the presence of Dicer-deficient cells. Initially highly enriched,
Dicer-deficient cells represented30%of the population at 10 days
after Cre treatment. However, the Dicer-deficient subpopulation
was rapidly depleted and, by 2 weeks after Cre transfection, was no
longer detectable by Southern blot analysis (Fig. 2 A and B). These
results demonstrated that Dicer-deficient ES cells are at a growth
disadvantage compared with the Dicerflox/null cells, indicating the
absence of Dicer either causes a significant alteration in the growth
of ES cells or compromises their survival.
To distinguish between these possibilities, we plated Dicerflox/null
populations enriched for Cre-GFP transfection at clonogenic
densities. Single clones were picked 6 days after Cre transfection
and analyzed by PCR for recombination between loxP sites.
Among different experiments, between 50% and 90% of clones
analyzed had undergone Cre-mediated excision events. Clones
were then transferred to individual wells of a 96-well plate and
cultured in isolation either on gelatin or on an irradiated feeder
layer. Strikingly, within 1 week of culture in individual wells, all
clones that had not undergone Cre-mediated excision events had
achieved confluence, whereas no Dicer-deficient clones had
reached a similar density. After several weeks, a small number
of these Dicer-deficient clones had proliferation rates sufficient
to establish continuous Dicer-deficient cell lines. In this study we
primarily analyzed two representative Dicer-deficient cell lines
isolated from populations derived on gelatin. For comparison,
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we also examined a cell line that retains the original genotype
(Dicerflox/null) despite having been exposed to Cre recombinase
and isolated alongside the Dicer-null cell lines from a single
parental cell line.
The significant proliferation lag seen in Dicer-deficient cells is
consistent with the possibility that loss of Dicer leads primarily
to an acute loss of proliferative potential that can eventually be
rescued by the accumulation of compensatory events, either
mutations or stable changes in gene expression. These ‘‘escap-
ers’’ eventually achieve a growth rate slower than, but approach-
ing that of Dicer wild-type or heterozygous cells. Interestingly,
the Dicer-deficient escapers have an altered cell-cycle profile, as
compared with Dicerflox/null cells, with a slight increase in G1 and
G0 cells and a corresponding decrease of cells in G2 and M (see
Fig. 5, which is published as supporting information on the PNAS
web site). Originally measured 6 weeks after Dicer loss, the
escapers retained this altered profile henceforth. One possibility
is that the escapers have undergone a program of differentiation
and have adopted a cell-cycle profile characteristic of another
cell type; however, the Dicer-null cells robustly express some ES
cell markers including Oct-4 (data not shown). The presence of
a feeder layer both enhanced the survival rate and reduced the
proliferation delay in Dicer-deficient ES cells, although these
growth conditions did not affect either survival or growth rate
of Dicer heterozygous or wild-type ES cells. It seems likely that
feeder cells supply factors in trans to Dicer-deficient ES cells or
that growth of Dicer-deficient ES cells is sensitive to cell density.
Properties of Dicer-Deficient ES Cells. The genotypes of Dicer-
deficient cell clones were confirmed by Southern blotting, along-
side heterozygous Dicerfloxed/null clones and parental 129-derived
wild-type ES cell clone AB2.2 (Fig. 1C). No full-length Dicer
protein could be detected in flox-excisednull ES cell whole-cell
extracts by Western blotting by using antibodies recognizing
either the N or C termini of Dicer (Fig. 3 A and B).
It was predicted that the single mouse Dicer enzyme would be
responsible for processing of pre-miRNAs into mature miRNAs
and for processing of long dsRNAs into siRNAs to initiate
posttranscriptional gene silencing. To test whether mouse Dicer
is responsible for pre-miRNA processing, we analyzed mature
miRNA accumulation in Dicer-deficient cells. Northern blotting
using several miRNA probes revealed, as expected, a complete
Fig. 2. Dicer-null cells show proliferation defects. (A) Dicer floxed ES cells
were transiently transfected with a Cre-GFP expression plasmid and sorted for
GFP-positive cells, and the population was analyzed at different times after
Cre expression by Southern blotting. The Dicerflox(excised)/null population was
lost from the mixed population at 10–15 days after excision. (B) The relative
representation of the Dicerflox(excised)/null versus the Dicerflox/null cells in the
population was quantified by image analysis of the gel shown in A.
Fig. 1. Conditional Dicer ES cells. (A) Dicer domain structure. Dicer floxed allele was created by knocking in a floxed cassette, flanking the RNaseIII
domain-encoding exons 22 and 23 with loxP sites. (B) ES cells that are heterozygous for a Dicer-null allele (created by deletion of an RNaseIII domain) have
previously been described (1). The introduction of the Dicer floxed allele into these ES cells created Dicer floxed ES cells. Treatment with Cre leads to excision
of the majority of both RNaseIII domains, creating a second nonfunctional allele. The four different Dicer alleles (wild-type, null, conditional but not excised,
and conditional excised) can be distinguished by Southern blotting. (C) A Southern blot used to confirm the genotypes of the cell lines used in this study is shown.






absence of mature miRNAs in Dicer-deficient cells and, in some
cases, a slight accumulation of Dicer substrates, the pre-miRNAs
(Fig. 3 C and D).
ES cells have previously been shown to lack prominent nonspe-
cific (e.g., PKR) responses to long dsRNAs and instead to mount
a sequence-specific silencing response to these triggers (37, 39, 40).
To confirm that Dicer is essential for these sequence-directed
responses, we transfected 500-bp dsRNAs corresponding in se-
quence to either firefly luciferase or GFP into our Dicer-deficient
cells and their Dicer-expressing siblings. Wild-type and heterozy-
gous ES cell lines were greatly reduced in firefly luciferase activity
when transfected with firefly dsRNA, as compared with cells
transfected with GFP dsRNA (Fig. 3E). However, Dicer-deficient
cells failed to silence firefly luciferase to a significant extent after
firefly dsRNA treatment (Fig. 3E). Considered together, these
studies confirm that a single mouse Dicer enzyme is required for
both miRNA and dsRNA processing pathways.
Responses to siRNAs. Synthetic siRNAs mimic Dicer cleavage prod-
ucts and presumably act downstream of Dicer. Therefore, there is
not an a priori expectation that these RNAi triggers would require
Dicer for their action. However, previous studies concluded that
Dicer is required for siRNAs to trigger silencing inmammalian cells
(41). Therefore, we asked whether siRNAs are functional in the
absence of Dicer in mouse ES cells.
We transfected a mixture of a firefly luciferase siRNA and a
second siRNA that does not target our reporter into cells,
varying the concentration of the relevant siRNA but keeping the
overall siRNA concentration constant. When the dual luciferase
activity was analyzed 48 h after transfection, there was a clear
concentration-dependent reduction in firefly luciferase activity.
Interestingly, the effect was comparable in wild-type ES cells
(AB2.2), Dicerflox/null cells, or cells that are null for Dicer (Fig.
3F). These studies suggested that siRNAs can indeed enter RISC
and function in the absence of an active Dicer protein in
mammals. It has been reported elsewhere that Dicer-deficient
mammalian cells are competent for siRNA-mediated silencing
(19). Our data extend these findings by showing that lack of
Dicer does not change the IC50 for inhibition by a small RNA.
Accumulation of Centromeric Transcripts in Dicer-Deficient ES Cells. In
a number of organisms, RNAi has been implicated in the regulation
of heterochromatin, especially at centromeres (17, 20, 22, 23,
25–27). It has been suggested that transcripts derived from hetero-
chromatic repeats are recognized and processed by Dicer, produc-
ing siRNAs that enter complexes involved in nucleating or main-
taining centromeric heterochromatin (20, 24, 42). Mouse
centromeres are composed of highly repetitive heterochromatic
loci, divided into two classes of repeats known as the major satellite
and the minor satellite. In accord with the situation previously
characterized in S. pombe, transcripts derived from both strands of
the satellite repeats have been detected inmouse cells and inmouse
embryos (18, 19, 38, 43, 44). Therefore, these studies are consistent
with a possible role of Dicer in maintaining the integrity of
mammalian centromeres.
To investigate the role of Dicer at mammalian centromeres, we
used RT-PCR to quantify transcript accumulation from the major
satellite repeats. Using actin as a standardization control, we found
an accumulation ofmajor satellite transcripts in cDNAprimedwith
randomprimers, oligo(dT), andmajor satellite-specific primers (see
Fig. 6, which is published as supporting information on the PNAS
web site). This effect was quantified, and Dicer-deficient cells
showed a consistently greater than 2-fold increase in major satellite
transcript levels, as comparedwith heterozygous andwild-type cells
(AB2.2) (Fig. 4A).
There are several possible interpretations of these findings. In
one model, loss of Dicer would lead to deconstruction of centro-
meric heterochromatin, similar to what is seen in S. pombe. The
status of heterochromatin at centromeres can be monitored in part
by examining patterns of cytosine methylation, one important
marker of constitutive heterochromatin in mammals. We used
Fig. 3. Dicer-null ES cells do not process dsRNA or pre-miRNAs but are able
to respond to siRNAs. No full-length Dicer protein can be detected in whole-
cell lysates of Dicer-deficient cells. (A) Western blotting using an antibody
recognizing the RNaseIII domains of Dicer. (B) Western blotting using an
antibody recognizing the PAZ domain of Dicer. Dicer-null ES cells fail to
process pre-miRNAs into mature miRNAs. Total RNA extracted from floxed
null and floxed excisednull ES cells was probed with 32P-labeled oligonucle-
otides complementary to miR-19b (with equal loading indicated by blotting
for U6 snRNA) (C) or miR-293 and miR-292-as (D). (E) Dicer-null ES cells fail to
initiate gene silencing in response to dsRNA. dsRNAs, 500 nt in length, corre-
sponding to either firefly luciferase or GFP were introduced into ES cells along
with firefly and Renilla luciferase reporters. (F) Standard dual luciferase assays
were performed on ES cells transfected with siRNAs.
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methylation-sensitive restriction enzymes to assay the methylation
status of the major and minor satellite repeats by Southern blotting
in cells that contain or lack an active Dicer enzyme. Genomic DNA
from cells of various genotypes was cut with either MspI (methyl-
ation insensitive) or HpaII (methylation sensitive) and hybridized
withmajor satellite orminor satellite probes.AmitochondrialDNA
probe served as a loading control. We did not observe any
significant change in themethylation status of centromeric satellites
in cells irrespective of their Dicer genotype (Fig. 4B). To determine
whether histone methylation is altered at the centromeres in
Dicer-null cells, we used chromatin immunoprecipitation assays
with antibodies specific to histone H3 trimethyl lysine 9, a histone
modification characteristic of pericentric heterochromatin (44).We
found no change in the enrichment of either modification at the
major satellite repeats in Dicer-null cells, although there was a
significant decrease in the enrichment of the histone H3 trimethyl
lysine 9 modification at the pericentric region in Suv39h1 and h2
double null mouse embryonic fibroblasts (Fig. 4C) (45, 46). These
results raise another possibility, namely that pericentric heterochro-
matin remains intact and that Dicer and the RNAi machinery are
Fig. 4. Changes in centromeric RNA levels in Dicer-null cells but no change in histone modification status or cytosine methylation in Dicer-null cells. (A) RT-PCR
was used to quantify centromere-derived transcripts. (B) Southern blotting was used to determine the methylation status of the major and minor satellite repeats.
(C) Antibodies directed against trimethyl histone H3 lysine 9 were used for chromatin immunoprecipitations at the major satellite repeats. Immunoprecipitate
(with or without antibody) and input were amplified with primers specific to major satellite repeats with 20 cycles. Along with Dicer wild-type, heterozygous,
and null are shown Suv39h1 and h2 double null mouse embryonic fibroblasts together with wild-type mouse embryonic fibroblast controls.






normally involved in degrading transcripts that are generated from
these repeated loci. These studies do not rule out the possibility that
Dicer might be involved in initiating DNA methylation at centro-
meric regions, e.g., during neocentromere formation.
Discussion
We have constructed floxed Dicer mouse ES cell lines that can be
induced by Cre recombinase to excise the catalytic RNaseIII
domain-encoding exons of Dicer. This system has allowed us to
examine the acute effects of Dicer loss on ES cells in culture as well
as to establish Dicer-deficient cell lines.
Studies of Dicer-deficient animals have revealed that Dicer
plays critical roles during development (1, 14, 15). However, in
part owing to the extremely early lethality in Dicer-deficient
organisms, the causes underlying the phenotypes have remained
unclear. Using our floxed Dicer ES cell line, we have shown that
loss of Dicer in ES cells leads to a pronounced proliferation
defect, an effect that can be eventually partially overcome,
perhaps by accumulation of secondary mutations. This pheno-
type could result from an absence of one or more mature
miRNAs, perhaps one required to repress a cell-cycle inhibitor
that would otherwise be expressed in ES cells. Alternatively, a
more global effect on genome organization and structure could
trigger checkpoint responses that arrest proliferation.
We show here that removal of Dicer from ES cells also results in
accumulation of transcripts derived from the major satellite of the
mouse centromere. Additionally, the transcripts seem to be dynam-
ically regulated duringmouse development (18, 43).Dicer-deficient
ES cells similarly have a clearly increased level of major satellite
transcripts, but we cannot distinguish between the possibilities that
this is due to transcript stabilization or a secondary effect of loss of
Dicer on the expression of a gene that normally controls expression
from centromeres. Interestingly, we detect no effect ofDicer loss on
cytosine methylation or histone H3 lysine 9 trimethylation status at
the centromeres. Thus, our results suggest that Dicer is dispensable
for the maintenance of pericentric heterochromatin in mouse.
A recent study has shown that Dicer is required by mouse ES
cells for differentiation in vitro and in vivo and that loss of Dicer
can lead to transcriptional derepression of major and minor
satellite repeats accompanied by loss of cytosine methylation at
these regions (19). In our current study, however, we were unable
to detect DNAmethylation defects in ES cells deficient in Dicer.
There are several explanations for these apparently contradic-
tory results. It is possible that small amounts of catalytically inert,
truncated Dicer protein are produced from either or both the
allele described here or that described by C. Kanellopoulou et al.
(19) and that this is sufficient to retain or perhaps inhibit
cytosine methylation at the centromeres. Alternatively, perhaps
selective pressure accompanied by prolonged cell culture has led
to two distinct outcomes with respect to DNAmethylation at the
major and minor satellite repeats. Interestingly, loss of Dicer in
developing mouse thymocytes leads to no apparent loss of
constitutive heterochromatin, suggesting that there may be
cell-type-specific regulation of heterochromatin.
The observations indicate that Dicer-deficient ES cells retain
their ability to incorporate siRNAs into RISC. Thus, RISC loading
inmammalsmust differ in someway from the process that has been
studied inDrosophila. Inmice, loading of siRNAsmay dependmore
heavily on an as yet unidentified ortholog ofDrosophilaR2D2, with
the role played by Dicer in this process being either diminished or
completely eliminated. Of course, we cannot absolutely eliminate
the possibility that small amounts of a truncated, catalytically inert
Dicer protein are produced in our Dicer-null cells that might be
selectively able to participate in RISC assembly.
The conditional Dicerflox/null ES cell that we have generated will
be useful in dissecting in a mammalian setting the many roles of
Dicer and, by implication, the RNAimachinery, in gene regulation,
genomic organization, and genome defense.
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